What is Trastuzumab 440mg and how does it work?
Trastuzumab 440mg is a drug that is used to treat cancers of the breast, stomach, and esophagus. This medicine is used to treat cancers that produce an excessive amount of a chemical known as HER2 protein. Trastuzumab is a monoclonal antibody, which means it belongs to a class of drugs called monoclonal antibodies.
Trastuzumab is a type of chemotherapy.
Trastuzumab is a monoclonal antibody that is used to treat metastatic (spread) breast cancer. It works against cancers that have an overabundance of the HER2/neu protein. as part of an adjuvant chemotherapy regimen for lymph-node-positive, HER2/neu protein-positive breast cancer patients. Gastric (stomach) cancer treatment
What are the Trastuzumab 440mg side effects?
- congestive heart failure
- and the rash is the most prevalent adverse effect found in the treatment of metastatic breast cancer (based on intravenous trastuzumab).
- For additional information on the benefits and hazards of HERCEPTIN HYLECTA, speak with a healthcare practitioner.
For more details Click Here.
Trastuzumab 440mg is an antibody, right?
Trastuzumab is a humanized monoclonal antibody that binds to the HER2 extracellular domain IV. In 1998, the Food and Drug Administration (FDA) approved the first anti-HER2 antibody, trastuzumab, for the treatment of patients with HER2-overexpressed metastatic breast cancer.
What is the efficacy of Trastuzumab 440mg?
A 2014 study of almost 4000 patients found that adding trastuzumab to chemotherapy increased 10-year survival from 75.2 percent to 84 percent, resulting in a 37 percent relative improvement in overall survival. The disease-free survival rate climbed from 62.2 percent to 73.7 percent over a 10-year period. All patient groupings reaped the benefits.
Is Trastuzumab 440mg associated with hair loss?
Hair loss is not a common side effect of trastuzumab treatment. If you receive trastuzumab with chemotherapy, you may develop hair loss as a side effect of the chemotherapy.